Global Blockchain in Genomics Market to Reach $3.88 Billion by 2029

FREMONT, California, Oct. 11, 2019 /PRNewswire/ — According to a new market intelligence report by BIS Research titled “Global Blockchain in Genomics Market – Analysis and Forecast, 2018-2029,” the global blockchain in genomics market was valued at $15.7 million in 2018 and is projected to grow over $3.88 billion by 2029. The market is expected to grow at a significant compound annual growth rate (CAGR) of 66.42%, during the forecast period 2019-2029. The growth of the market is aided primarily by the prominent development in the underlying end-use sub-segments.

Browse 02 Market Data Tables 94 Figures spread through 147 Pages and in-depth TOC on “Global Blockchain in Genomics Market

With genomic data touted as being the major impetus behind the increasing transition toward precision medicine, high-throughput sequencing (HTS) technologies have evolved rapidly, resulting in becoming the most powerful tools available for biological research. However, the volume of data being currently generated by these platforms is enormous. This is leading to a scenario wherein computational analyses represent the biggest bottleneck. With petabytes of data being generated on a global level with increasing sequencing activities, this number is soon to reach exabytes of data, demanding modern solutions that lean toward utilizing professional infrastructures with the capability of bearing such loads.

While data aggregators such as 23andMe, MyHeritage, and AncestryDNA have been synonymous with providing valuable insights to consumers with respect to their genetic composition, the industry requires an understanding revolves around the fact that only consumers reserve the right to share and monetize their genetic data. As a result, there has been an insurgence of companies employing blockchain to store, exchange, and secure genetic data resulting from an increasing number of sequencing activities. While blockchain is providing tremendous opportunities for growth in the genomics industry, consequently advancing the precision medicine gamut, skepticism continues to plague the associated potential that this technology consists.

BIS Research Report: https://bisresearch.com/industry-report/blockchain-in-genomics-market.html

According to Nitish Singh, Lead Analyst at BIS Research, “North America is currently the leading contributor to the global blockchain in genomics market, with a share of approximately 61.81% in the global market value in 2018. This region is anticipated to grow at a double digit CAGR during the forecast period 2019-2029 and to continue dominating the global market in 2029 as well. However, the Asia-Pacific region is expected to grow at a significant CAGR during the forecast period 2019-2029. The Europe region also contributed a significant share of 20.14% in the global market in 2018 and is anticipated to grow at a CAGR of 68.83% during the forecast period from 2019-2029.”

Research Highlights:

  • Data sharing and monetization is expected to witness a robust CAGR during the forecast period 2019-2029. However, the data storage and security application segment is anticipated to experience the fastest growth during the forecast period 2019-2029.
  • Pharmaceutical and biotechnology companies is expected to continue to dominate the global blockchain in genomics market throughout 2029, contributing a share of approximately 49.09% of the market in 2018 and 43.80% in 2029 . However, research institutes segment is expected to grow at the highest CAGR during the forecast period 2019-2029, owing to the end-use segment becoming the epicenter of genomic data generation.

Request for a Sample: https://bisresearch.com/requestsample?id=759&type=download

This market intelligence report provides a multi-dimensional view of the global blockchain in genomics market with the help of key factors driving the market, restraints that can possibly inhibit the overall growth of the market, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

The competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches and approvals, partnerships, collaborations, business expansions, as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales, manufacturers, service providers, and trend analysis by segment, and growth share analysis by region. Additionally, the report provides a comprehensive attractive analysis and opportunity analysis for the entire global blockchain in genomics market for 2018 and 2029.

This report is a meticulous compilation of research on more than 25 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 10 leading companies, market participants, and vendors. The report also comprises 11 detailed company profiles including several key players, such as Digital DNAtix Ltd., ENCRYPGEN INCORPORATED, Genobank.io Inc., Genomes.io, Longenesis, LunaDNA, LLC, Nebula Genomics, Inc., Shivom Ventures Limited, SimplyVital Health, Inc., WuXi Nextcode Genomics, Inc., and Zenome.io Ltd.

Key Questions Answered in the Report

  • What was the revenue generated by the market in 2018? What is the expected revenue for 2029?
  • What are the major market drivers, challenges, and opportunities in the global blockchain in genomics market?
  • What are the underlying structures resulting in the emerging trends within the global market?
  • What are the key regulatory implications in the global blockchain in genomics market?
  • What is the revenue expected to be generated by each segment of the market for the forecast period 2019-2029, on the basis of:
    • Models: B2B business model, B2C business model, and C2C business model.
    • Service: utility tokens, and blockchain platforms
    • Application: data sharing and monetization, data storage and security, and automated health insurance
    • End user: pharmaceutical and biotechnology companies, hospitals and healthcare providers, research institutes, data owners, and other end users
    • Region: North America, Europe, Asia-Pacific, and Rest-of-the-World (ROW)
  • Who are the leading market players with significant offerings in the global blockchain in genomics market?
  • What are the key development strategies which are implemented by the major players in order to exist in the competitive market?
  • What are the major knowledge gaps in the market? How are emerging businesses tackling these gaps to enhance consumer adoption?
  • Which companies are anticipated to be highly disruptive in the future and why?

Related Reports:

Global Direct-to-Consumer Genetic Testing (DTC-GT) Market – Analysis and Forecast, 2019-2028

Global Pharmacogenomics Market – Analysis and Forecast, 2019-2028

Global Single Cell Multi-Omics Market – Analysis and Forecast, 2019-2025

Global Clinical Decision Support Systems Market – Analysis and Forecast, 2019-2028

China Precision Medicine Market – Analysis and Forecast, 2019-2029

Global Cell and Gene Therapy Market – Analysis and Forecast, 2019-2025

Global Molecular Diagnostics Point of Care Market – Analysis and Forecast, 2019-2029

Global Blockchain in Healthcare Market – Analysis and Forecast, 2018-2025

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ http://bisresearch.com/blog/ 
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research 
Connect with us on Twitter@ https://twitter.com/BISResearch

View original content:http://www.prnewswire.com/news-releases/global-blockchain-in-genomics-market-to-reach-3-88-billion-by-2029–300937069.html

SOURCE BIS Research

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

9 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

9 hours ago